Assessing the potential of a "color effect" for hair analysis of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol: Analysis of a large sample of hair specimens

Life Sciences

Volumn 74, Issue 4, 2003, Pages 463-469

  Mieczkowski, Tom ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

11 nor 9 carboxy 9 tetrahydrocannabinol; Hair analysis; Hair color

Indexed keywords

TETRAHYDROCANNABINOLIC ACID;

ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GAS CHROMATOGRAPHY; HAIR ANALYSIS; HAIR COLOR; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; RADIOIMMUNOASSAY; SAMPLE SIZE; SCALP HAIR; STATISTICAL SIGNIFICANCE;

EID: 0242721884     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.06.037     Document Type: Article

References (21)

1. Bachman R., Paternoster R. Statistical Methods for Criminology and Criminal Justice. 1997;McGraw Hill, New York.
2. Baumgartner W., Hill V., Kippenburger D. Workplace drug testing by hair analysis. Mieczkowski T. Drug Testing Applications. 1999;313-348 CRC Press, Boca Raton, Florida.
3. Cook R. Assessing drug use in the workplace: A comparison of self-report, urinalysis, and hair analysis. Hughes A., Harrison L. Monograph NIDA #167. 1997;161-199 US Government Printing Office, Washington, DC.
4. Henderson, G., Harkey, M., Jones, R., 1993. Final Report: Hair analysis for drugs of abuse. National Institute of Justice, Grant #90-NIJ-CX-0012, Washington, DC.
5. Henderson G., Harkey M., Zhou C., Jones R., Jacob P. Incorporation of isotopically labeled cocaine into human hair: Race as a factor. Journal of Analytical Toxicology. 22:1998;156-165.
6. Hoffman B.H. Analysis of race effects on drug-test results. Journal of Occupational and Environmental Medicine. 41:1999;612-614.
7. Joseph R., Tsung-Ping S., Cone E. In vitro binding studies of drugs to hair: Influence of melanin and lipids on cocaine binding to Caucasoid and Africoid hair. Journal of Analytical Toxicology. 20:1996;338-344.
8. Kelly R., Mieczkowski T., Sweeney S., Bourne J. Hair analysis for drugs of abuse: Hair color and race differentials or systematic differences in drug prevalence? Forensic Science International. 107:2000;63-86.
9. Kidwell D., Blank D. Hair analysis: Techniques and potential problems. Sunshine I. Recent Developments in Therapeutic Monitoring and Clinical Toxicology. 1992;555-563 Marcel Dekker, New York.
10. Kidwell D. Is hair testing culturally biased and why is this a concern in the U.S.? Presentation at the Second European Meeting on Hair Analysis, Martigny, Switzerland, June 14-16:1999.
11. Knight K. The validity of self-reported cocaine use in a criminal justice treatment sample. American Journal of Drug and Alcohol Abuse. 24:1998;647-660.
12. Kronstrand R., Forstberg-Peterson S., Kagedal B., Ahlner J., Larson G. Codeine concentrations in hair after oral administration is dependent on melanin content. Journal of Clinical Chemistry. 45:1999;1485-1494.
13. Mangin P. Hair analyses and their acceptance in court. de Zeeuw R., Hosani I., Al Munthiri S. Proceedings of the International Conference and Workshop for Hair Analysis in Forensic Toxicology. 1995;482-487 United Arab Emirates Press, Abu Dhabi.
14. Mieczkowski T. Is a color effect demonstrated for hair analysis of carbamazepine? Life Sciences/Pharmacology Letters. 67(1):2000;39-43.
15. Mieczkowski T., Tsatsakis A., Psillakis A., Kruger M. The concentration of three anti-seizure medications in hair: The effects of hair color, controlling for dose and age. Clinical Pharmacology. 1(2):2001;1-33.
16. Mieczkowski T. The effect of color and curvature on the concentration of morphine in hair analysis. Forensic Science Communications. 3(4):2001;1-5.
17. Nakahara Y. The effects of physiochemical factors on incorporation of drugs into hair and the behavior of drugs in hair root. Mieczkowski T. Drug Testing Applications. 1999;49-73 CRC Press, Boca Raton, Florida.
18. Uematsu T., Sato R., Suzuki K., Yamaguchi S., Nakashima M. Human scalp hair as evidence of individual dosage history of Haloperidol: Method and retrospective study. European Journal of Clinical Pharmacology. 37:1989;239-244.
19. Uematsu T., Sato R. Human scalph Hair as evidence of individual dosage history of Haloperidol: Longer-term follow-up study. Therapeutic Drug Monitoring. 12:1990;582-583.
20. Uematsu T., Nakashima M. Pharmacokinetic aspects of newer quinolones. Progress in Drug Research. 38:1992;39-55.
21. Uematsu T., Miyazawa N., Okazaki O., Nakashima M. Possible effect of pigment on the pharmacokinetics of ofloxacin and its excretion in hair. Journal of Pharmaceutical Sciences. 81(1):1992;45-48.